Therapy, Gene
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD) (NCT01024998) | Genzyme, a Sanofi Company | 2010-01-11 |
Track Therapy, Gene automatically
Every clearance here is in the API, with alerts when new ones post.